SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001104659-22-041835
Filing Date
2022-04-01
Accepted
2022-04-01 17:16:09
Documents
1
Period of Report
2021-12-31
Effectiveness Date
2022-04-01

Document Format Files

Seq Description Document Type Size
1 NT 10-K tm223777d2_nt10k.htm NT 10-K 26120
  Complete submission text file 0001104659-22-041835.txt   27250
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-39788 | Film No.: 22799372
SIC: 2834 Pharmaceutical Preparations